Research programme: immune modulation therapy - Psionix
Latest Information Update: 20 Apr 2007
At a glance
- Originator Psionix
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Immunological disorders
Most Recent Events
- 07 Oct 2003 Preclinical trials in Immunological disorders in United Kingdom (unspecified route)